A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
;
Joe Dennis ;
Jonathan P Tyrer ;
Daniel R Barnes ;
LesleyMcGuffog;
Goska Leslie ;
Manjeet KBolla;
+214 more...
Muriel AAdank;
SimonaAgata;
Thomas Ahearn ;
KristiinaAittomäki;
Irene L Andrulis ;
HodaAnton-Culver;
Volker Arndt ;
NorbertArnold;
Kristan JAronson;
Banu KArun;
AnnelieAugustinsson;
Jacopo Azzollini ;
Daniel Barrowdale ;
CarolineBaynes;
Heiko Becher ;
MarinaBermisheva;
Leslie Bernstein ;
KatarzynaBiałkowska;
CarlBlomqvist;
Stig E Bojesen ;
Bernardo Bonanni ;
AkeBorg;
Hiltrud Brauch ;
HermannBrenner;
BarbaraBurwinkel;
Saundra SBuys;
Trinidad Caldés ;
Maria ACaligo;
DanieleCampa;
Brian DCarter;
Jose ECastelao;
JennyChang-Claude;
Stephen J Chanock ;
Wendy K Chung ;
Kathleen BM Claes ;
Christine LClarke;
GEMO Study Collaborators;
EMBRACE Collaborators;
J Margriet Collée ;
Don MConroy;
KamilaCzene;
Mary BDaly;
Peter Devilee ;
OrlandDiez;
Yuan ChunDing;
Susan MDomchek;
Thilo Dörk ;
Isabel Dos-Santos-Silva ;
Alison M Dunning ;
Miriam Dwek ;
Diana MEccles;
A Heather Eliassen ;
ChristophEngel;
MikaelEriksson;
D GarethEvans;
Peter AFasching;
HenrikFlyger;
FlorentiaFostira;
EitanFriedman;
Lin Fritschi ;
DebraFrost;
ManuelaGago-Dominguez;
Susan MGapstur;
JudyGarber;
VanesaGarcia-Barberan;
Montserrat García-Closas ;
José A García-Sáenz ;
Mia MGaudet;
Simon A Gayther ;
AndreaGehrig;
VassiliosGeorgoulias;
Graham G Giles ;
Andrew KGodwin;
Mark SGoldberg;
David EGoldgar;
AnnaGonzález-Neira;
Mark H Greene ;
Pascal Guénel ;
LotharHaeberle;
EricHahnen;
Christopher AHaiman;
Niclas Håkansson ;
PerHall;
UteHamann;
Patricia AHarrington;
Steven N Hart ;
Wei He ;
Frans BLHogervorst;
Antoinette Hollestelle ;
John LHopper;
Darling JHorcasitas;
Peter J Hulick ;
David JHunter;
Evgeny NImyanitov;
KConFab Investigators;
HEBON Investigators;
ABCTB Investigators;
AgnesJager;
Anna Jakubowska ;
Paul A James ;
Uffe Birk Jensen ;
Esther MJohn;
Michael E Jones ;
RudolfKaaks;
Pooja Middha Kapoor ;
Beth YKarlan;
Renske Keeman ;
ElzaKhusnutdinova;
Johanna IKiiski;
Yon-DschunKo;
Veli-MattiKosma;
Peter Kraft ;
Allison W Kurian ;
YaelLaitman;
Diether Lambrechts ;
LoicLe Marchand;
JennyLester;
Fabienne Lesueur ;
TriciaLindstrom;
AdriaLopez-Fernández;
Jennifer TLoud;
CraigLuccarini;
ArtoMannermaa;
SiranoushManoukian;
SaraMargolin;
John WM Martens ;
NouraMebirouk;
AlfonsMeindl;
Austin Miller ;
Roger L Milne ;
MarcoMontagna;
Katherine L Nathanson ;
Susan LNeuhausen;
Heli Nevanlinna ;
Finn CNielsen;
Katie MO'Brien;
Olufunmilayo I Olopade ;
Janet E Olson ;
HåkanOlsson;
AnaOsorio;
Laura Ottini ;
Tjoung-WonPark-Simon;
Michael T Parsons ;
Inge Sokilde Pedersen ;
Beth Peshkin ;
Paolo Peterlongo ;
Julian Peto ;
Paul DP Pharoah ;
Kelly-AnnePhillips;
Eric CPolley;
BrucePoppe;
NadegePresneau;
Miquel AngelPujana;
Kevin Punie ;
Paolo Radice ;
JohannaRantala;
Muhammad URashid;
Gad Rennert ;
Hedy SRennert;
Mark Robson ;
Atocha Romero ;
MariaRossing;
Emmanouil Saloustros ;
Dale P Sandler ;
ReginaSantella;
Maren TScheuner;
Marjanka K Schmidt ;
GunnarSchmidt;
Christopher Scott ;
PriyankaSharma;
PennySoucy;
Melissa CSouthey;
John JSpinelli;
ZoeSteinsnyder;
Jennifer Stone ;
DominiqueStoppa-Lyonnet;
AnthonySwerdlow;
Rulla MTamimi;
William JTapper;
Jack ATaylor;
Mary BethTerry;
AlexTeulé;
Darcy LThull;
MarcTischkowitz;
Amanda E Toland ;
DianaTorres;
Alison HTrainer;
Thérèse Truong ;
NadineTung;
Celine M Vachon ;
Ana Vega ;
Joseph Vijai ;
QinWang;
BarbaraWappenschmidt;
Clarice RWeinberg;
Jeffrey N Weitzel ;
CamillaWendt;
Alicja Wolk ;
Siddhartha Yadav ;
Xiaohong RYang;
Drakoulis Yannoukakos ;
WeiZheng;
Argyrios Ziogas ;
Kristin K Zorn ;
Sue K Park ;
MadsThomassen;
KennethOffit;
Rita KSchmutzler;
Fergus JCouch;
Jacques Simard ;
GeorgiaChenevix-Trench;
Douglas F Easton ;
NadineAndrieu;
Antonis CAntoniou;
(2021)
A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.
Nature communications, 12 (1).
1078-.
ISSN 2041-1723
DOI: 10.1038/s41467-020-20496-3
Breast cancer (BC) risk for BRCA1 and BRCA2 mutation carriers varies by genetic and familial factors. About 50 common variants have been shown to modify BC risk for mutation carriers. All but three, were identified in general population studies. Other mutation carrier-specific susceptibility variants may exist but studies of mutation carriers have so far been underpowered. We conduct a novel case-only genome-wide association study comparing genotype frequencies between 60,212 general population BC cases and 13,007 cases with BRCA1 or BRCA2 mutations. We identify robust novel associations for 2 variants with BC for BRCA1 and 3 for BRCA2 mutation carriers, P < 10-8, at 5 loci, which are not associated with risk in the general population. They include rs60882887 at 11p11.2 where MADD, SP11 and EIF1, genes previously implicated in BC biology, are predicted as potential targets. These findings will contribute towards customising BC polygenic risk scores for BRCA1 and BRCA2 mutation carriers.
-
picture_as_pdf - s41467-020-20496-3.pdf
-
subject - Published Version
-
- Available under Creative Commons: NC-ND 3.0
Explore Further
Read more research from the creator(s):
Find work associated with the faculties and division(s):
Find work from this publication: